Linked Life Data

6346631

Source:http://linkedlifedata.com/resource/pubmed/id/6346631

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1983-8-26
pubmed:abstractText
Chemotherapy for prostate cancer has been demonstrated by the Clinical Trials Program of the NPCP and by other cooperative and individual studies both as single antitumor agents and combinations of agents to provide additional benefit to patients with advanced disease that no longer respond to hormonal therapy, markedly more so than could be provided by a host of palliative and real or synthetic hormonal agents commonly used in this type of patient. There is also some evidence to support the premise that adding antitumor agents to hormones as initial treatment for metastatic disease is more effective than waiting for the ultimate hormone failure, at least in patients with poorer prognosis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0090-4295
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
A decade of experience with chemotherapy for prostate cancer.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Review